Skip to main content
. Author manuscript; available in PMC: 2014 Jun 14.
Published in final edited form as: Biochem Biophys Res Commun. 2013 May 18;435(4):646–650. doi: 10.1016/j.bbrc.2013.05.038

Figure 4.

Figure 4

Bivalent peptide DV1-K-(DV3) showed significant anti-HIV activity and no cytotoxicity. A. HIV-1 inhibition in the drug screening assay. B. No cellular toxicity in the LIVE DEAD cytotoxicity assay.